Shareholders Foundation, Inc.

TG Therapeutics, Inc. (NASDAQ:TGTX) Long Term Investor Alert: Investigation of Potential Wrongdoing

An investigation on behalf of current long term investors in TG Therapeutics, Inc. (NASDAQ:TGTX) shares over possible breaches of fiduciary duty by certain officers and directors was announced.

 

San Diego, CA -- (SBWIRE) -- 11/03/2022 -- Certain directors of TG Therapeutics, Inc. are under investigation concerning potential breaches of fiduciary duties.

Investors who are current long term investors in TG Therapeutics, Inc. (NASDAQ: TGTX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for investors in NASDAQ: TGTX stocks follows a lawsuit filed against TG Therapeutics, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: TGTX stocks, concerns whether certain TG Therapeutics, Inc. directors are liable in connection with the allegations made in that lawsuit.

The plaintiff alleges that, the Defendants made false and/or misleading statements and/or failed to disclose that clinical trials revealed significant concerns related to the benefit-risk ratio and overall survival data of Ublituximab and Umbralisib, that accordingly, it was unlikely that the Company would be able to obtain FDA approval of the Umbralisib MZL/FL NDA, the U2 BLA, the U2 sNDA, or the Ublituximab RMS BLA in their current forms, that as a result, the Company had significantly overstated Ublituximab and Umbralisib's clinical and/or commercial prospects, and that therefore, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of TG Therapeutics, Inc. (NASDAQ: TGTX) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.